Valuing the effect sizes hypothesized in phase 3 trials of targeted therapies in oncology
This abstract was not included in this publication as it was already published. See Annals of Oncology, Volume 27, Issue suppl_6, 1 October 2016, 317P (10.1093/annonc/mdw366.02) - Oxford University Press.
| Автори: | , , , , |
|---|---|
| Формат: | Conference item |
| Опубліковано: |
BioMed Central
2017
|